In the first study, ASE of TGFBR1, assessed by SNaPshot, was found in approximately 10% of CRC patients (15% of informative patients), agreeing with our initial report; however, no controls were included for comparison (Pasche et al, 2010). This evidence concerns the gene TGFBR1 and colorectal carcinoma.